![](/img/cover-not-exists.png)
Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications
Krishnamoorthy, Jothi, Rajesh, Kamindla, Mirzajani, Farzaneh, Kesoglidou, Polixenia, Papadakis, Andreas, Koromilas, Antonis E.Volume:
13
Language:
english
Journal:
Cell Cycle
DOI:
10.4161/cc.27726
Date:
March, 2014
File:
PDF, 1.82 MB
english, 2014